Back to Search
Start Over
Evaluation of a new automated immunoassay for the quantification of anti-Müllerian hormone
- Source :
- Practical Laboratory Medicine, Practical Laboratory Medicine, Elsevier, 2021, 25, pp.e00220. ⟨10.1016/j.plabm.2021.e00220⟩, Practical Laboratory Medicine, Vol 25, Iss, Pp e00220-(2021)
- Publication Year :
- 2021
- Publisher :
- Elsevier, 2021.
-
Abstract
- Objectives A newly developed fully automated Lumipulse G AMH method (Fujirebio Diagnostics) was recently introduced in clinical laboratories for quantitative determination of anti-Mullerian hormone (AMH) level in human serum or plasma. AMH has emerged as value-added biomarker in the assessment of ovarian reserve, in diagnosis of granulosa cells cancer and in the investigation of gonadal disorders. We compared Lumipulse G AMH assay performances with other methods largely applied for AMH measurements. Design and Methods The Lumipulse G AMH method based on two-step sandwich chemiluminescence enzyme immunoassay was assessed on Lumipulse G600II analyzer. The evaluation study included imprecisions, sensitivity and linearity whereas a comparison study was performed on a heterogeneous population of 114 patients by using the Elecsys AMH Plus assay on COBAS 8000 e602 module (Roche Diagnostics). Results Lumipulse G AMH system showed good repeatability (within-run imprecision) with CV values below 1% (0.5% and 0.9% for high and low serum pools). Similarly within-laboratory imprecision was assessed with CV values of 2.5% and 1.6% for high and low level controls respectively. A linearity regression formula of 1.0119x-0.067 with a coefficient of determination (r2) equal to 0.999 was obtained in a range from 0.044 to 22.42 ng/ml. Passing-Bablok regression analysis was performed for assay comparability of AMH measurements. Results were closely correlated (correlation coefficient = 0.997) with a regression equation (y = 1.230x-0.025) showing a positive slope. Also, Bland-Altman analysis confirmed a good agreement between Lumipulse G AMH and Roche Elecsys AMH Plus assays with a bias of 17.76% in a large measurement range. Conclusions The performance of Lumipulse G AMH system was highly comparable with that of Roche Elecsys AMH Plus assay although approximately 10% higher values of AMH levels were observed for Lumipulse AMH system at all range of concentrations. Nevertheless the Lumipulse G system seems to be largely suitable for quantitative determination of AMH level in small-scale laboratory because of the reduced size and the use of single cartridge per test assuring flexibility and easy handling.
- Subjects :
- Medicine (General)
030213 general clinical medicine
endocrine system
Coefficient of determination
[SDV]Life Sciences [q-bio]
Clinical Biochemistry
Automated immunoassay
030204 cardiovascular system & hematology
Anti-Müllerian hormone
Roche Diagnostics
Andrology
Method comparison
03 medical and health sciences
R5-920
0302 clinical medicine
Full Length Article
medicine
Ovarian reserve
Assessment of ovarian reserve
QD1-999
ComputingMilieux_MISCELLANEOUS
Radiological and Ultrasound Technology
biology
medicine.diagnostic_test
Chemistry
urogenital system
Repeatability
Emerging biomarker
Immunoassay
biology.protein
Comparison study
hormones, hormone substitutes, and hormone antagonists
Subjects
Details
- Language :
- English
- ISSN :
- 23525517
- Volume :
- 25
- Database :
- OpenAIRE
- Journal :
- Practical Laboratory Medicine
- Accession number :
- edsair.doi.dedup.....64f641a79ae4ea170591f44f17815f83
- Full Text :
- https://doi.org/10.1016/j.plabm.2021.e00220⟩